MetaCap

Arcutis Biotherapeutics Statistics

NASDAQ: ARQTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

26.36-0.81 (-2.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Arcutis Biotherapeutics by the numbers

Arcutis Biotherapeutics has a market capitalization of $3.33 billion based on 126.46M shares outstanding. Its trailing P/E ratio is 119.8, and its forward P/E is 24.1. The stock trades 5.4% below its 50-day average and 3.7% above its 200-day average.

Average daily trading volume is 2.58M shares, or about $68.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ARQT valuation vs. peer median

ARQT compared with the median of 8 peer companies
MetricARQTPeer medianDifference
Market cap$3.33B$3.37B-1%
Avg. volume2.58M1.83M+41%

Peer median across 8 companies: AMLX, VRDN, IRON, ELVN, PBLS, ABCL, VKTX, XERS.

Valuation

P/E (TTM)
119.82
Price / sales (latest FY)
8.86

Price and trading

Previous close
27.17
Open
26.89
Day range
26.29 – 27.46
52-week range
19.30 – 34.80
52-week change
-10.61%
Beta
—
Volume
1.29M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
3.33B
Pe
119.82
Forward Pe
24.09
Eps
0.22
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
34.80
Week52 Low
19.30
Avg Volume
2.58M
Shares Outstanding
126.46M
Ma50
27.86
Ma200
25.41
Earnings Date
Nov 4, 2026
Pct From52w High
-24.25%
Pct From52w Low
36.62%

Related